Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
C'mon. You know no one knows. I m as anxious as anyone but I hope it coincides with news. It's all been opinion and conjecture so far; and it's all been wrong. Lander is frustratingly doing the right thing and keeping the timing confidential until he want to announce it to the public. The only evidence that we are close is its release by the SEC to start trading. I'm ASSUMING that the only reason it's not trading is because tLander is holding it back for a reason.
Hoping Lander is completing partnership negotiations, preparing for Dcell, ODD, and tcell IND number updates, and preparing 4th IND submission on small molecule experiment success. Hit us with big news Dr. Lander.
Don't want to see RGBPP trading until news hits.
My ST ticket not changed, too. Fidelity changed it 5 days ago and OTC has the stock listed. What the hell ST.
Lander seems to be closer to the vest than Koos and is not issuing updates as often. I would really like to know what the heck is happening with the pref and ODD.
No change in Scottrade.
Clearly, The Grey Market is not where Landers wants this to trade and a listing on the OTCBB requires SEC reporting requirements that RGBP already meets. So, I'm assuming it's not going to trade until that paperwork is submitted and approved. I'm also assuming that will be this week but who knows?
Annoying that Scottrade has yet to update pref symbol.
Wow,stalking on Ihub? Must have a lot of free time. And I own that POS.
Not yet, sport. 115 is not 11.
That's the big question. Lander's bonus is tied to transacting a partnership with a BP whose sales exceed 250 million. He alluded to discussions with those kind of firms in his January letter. My assumption is that a partnership funds Hema and other INDs. Another source would come from grants accessible if they are successful with their ODD application. That would be partial funding but highly significant if achieved. Lander's alluded to their recent FF raise as funding an unspecified study that I'm assuming is their small molecule effort.
LMFAO. That's a domain name someone bought. It's not the real Sears as has been explained here many times. And whoever runs that site lists Snorenz for $40. If one bottle has been sold on that site in 3 years I'd be shocked.
Still waiting for collaboration Agreement with BP that I had hoped would have been Q1.
I'm cautiously encouraged that the delay was n trading involved an actual plan to commence pref trading with good news.
It has convertible debt and it's being diluted. The debt Ray owns could be converted into billions of shares. The dumping nag has been obvious. See share price.
Yes, and I would like to believe that Lander would be tactical and have a positive announcement coinciding with trade commencement.
I think they trade separately like any other set of common and pref. Fannie common is at 1.45 and pref about 3 times that. As far as being smart. I don't believe they're that good at precision SP management. I think it's been hard enough for them just to get the shares listed and trading at all.
? Why not. Look I love this company but RGPB started trading at noon on a Weds without fanfare. I also recall the MMs setting a high and low within seconds of .0001 and $1. Then it evened out. So when it starts don't get too happy or sad at any of the early transactions.
Either way it won't affect those who don't own any.
Preferreds tend to trade at 1 to 3 times common
What's keeping you? If you want to sell because you don't believe in the company, sell.
What's keeping you? If you want to sell because you don't believe in the company, sell.
Get ready to kick yourself when this flys.
LMFAO. Just looking for company. No shares? That's not a good strategy. Just s family squabble right now.
Harry.Lander@regenbiopharma.com
And one more thing. Everyone should email Lander's and let him know what BS that March FF dilution was and how it runs contrary to his own promise.
Technically, no but rhe point is not off target. I'm mightily pissed and in subsequent emails to Lander's I've made that clear. They need 150k, sell a million shares over two weeks. That is 1//4 of the dilution created by their FF program and the buyers are at the same basis as the rest of us. And Lander's Jan letter did suggest that dilution was being phased out. So, a big FF giveaway in late March is just bad news. Look at the action today.
Lander's needs to use this as his personal "inflection point" and tell Koos to FH next time this FF idea comes up.
Technically, no but rhe point is not off target. I'm mightily pissed and in subsequent emails to Lander's I've made that clear. They need 150k, sell a million shares over two weeks. That is 1//4 of the dilution created by their FF program and the buyers are at the same basis as the rest of us. And Lander's Jan letter did suggest that dilution was being phased out. So, a big FF giveaway in late March is just bad news. Look at the action today.
Lander's needs to use this as his personal "inflection point" and tell Koos to FH next time this FF idea comes up.
Just part of the scam. They've been diluting for 4 years now.
LMAO. That's the same source claiming Hema IND rejection. Whatever the prediction the opposite must be true.
Wrong again.
From your favorite PR
The mechanics of the acquisition is that of a simple asset purchase, with Medgen acquiring almost all of Alternaturals assets, in exchange for taking on most of Alternaturals outstanding debt.
It'll be back to 13 billion AS soon enough. The dilution is real. They raised the AS to 3 from 1.5 billion in Nov 2014 and are getting close enough to either raise the AS to 5 billion or R/S. It'll keep on going.
Nonsense. They diluted by 400 million shares last year. 400 million shares in 2014 and 400 million in 2013. They have huge convertible debt owned primarily by Barton. They have sales less than a hot dog stand and product reviews about Snorenz that suggest it's a disgusting taste, leaves an oily residue in the back of the throat and doesn't work. And that's the only product that has any sales.
MDIN has nothing great but skill at dilution. 3 and s half years and the PPD is at no bid every other day. Pathetic
ANAS, all bad. Empty shell. NO PRODUCTS. NO BUSINESS PLAN. Headed to trips.
Helpful to see what experiments the money raise is going to be used for. Like to see that in a PR.
This is all downside risk. Empty shell will always head toward trip zero one from these levels. Any enthusiasm is bag holder desperation.
Reply.
I see no reason not to share this reply.
It is very nice to meet you and I am glad you emailed me.
We had a lot of hand-wringing about accepting these terms. In the end, with the next set of experiments awaiting funding and a successful outcome likely creating a major inflection point for our shareholders, we elected to take the money. I can assure you that this money is critical for a major set of experiments and we hope to get to a point where dilution at this level will be meaningless based on the valuation we can command.
The science is going great, the fundraising is painful. Please bear with us.
I am very happy to speak directly if you like and please email me with any thoughts in the future.
My email to Landers.
Sir
Shareholder with close to 1 million shares. Very enthusiastic about RGBP science and progress but also very disappointed in the late March friends and family heavily discounted share sale reported in the 8k.
Your January letter suggested this practice was ending. Given
The OTC reputation Dr Koos has for dilution I am concerned that the share sale at less than 5 cents a share means the same for RGBP as happened with BMSN. And on shareholder comment boards your record of achievement, greatly deserved, is now tarnished with a dilution narrative.
Hoping this is the last of these kinds of sales and smart shareholder friendly funding options open up very soon.
Thanks
Can someone refresh me on Lander's email address? Like cv I'm disappointed at the end of March discounted sale of stock and would like to voice that concern.